Trials / Completed
CompletedNCT02813551
ToRsemide for pOstpartum HYpertension
Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 118 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Currently there is no intervention to prevent persistent postpartum hypertension in preeclamptic women. Physiologically, the use of a pharmacokinetically predictable loop-diuretic is a reasonable intervention to increase elimination of extra fluid accumulated secondary to preeclampsia.The purpose of this study is to assess if Torsemide reduces the incidence of persistent postpartum hypertension in preeclamptic women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Torsemide | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-07-28
- Completion
- 2017-09-09
- First posted
- 2016-06-27
- Last updated
- 2019-04-10
- Results posted
- 2019-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02813551. Inclusion in this directory is not an endorsement.